A PROSPECTIVE, COMPARATIVE, RANDOMIZED, MULTI-CENTER, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2A STUDY OF THE SAFETY AND EFFICACY OF CMX-2043 FOR PERIPROCEDURAL INJURY PROTECTION IN SUBJECTS UNDERGOING CORONARY ANGIOGRAPHY AT RISK OF RADIO-CONTRAST INDUCED NEPHROPATHY (CARIN)

Registry ID

CMX-2043-2AK

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

ISCHEMIX LLC

Start date

2014-09-08

Last update

2014-05-21

Conditions

• NEPHROPATHY
• CORONARY HEART DISEASE OR HIGH RISK OF CORONONARY HEART DISEASE

Related clinical trials

• A RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, INVESTIGATOR- AND PARTICIPANT-BLINDED PHASE 2A STUDY TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DFV890 FOR INFLAMMATORY MARKER REDUCTION IN ADULT PARTICIPANTS WITH CORONARY HEART DISEASE AND ELEVATED HSCRP
• ELIMINATE CORONARY HEART DISEASE

View on source registry